It is a nootropic drug invented in 1996 by a group Performing for Merck, Sharp and Dohme, which was the 1st compound developed which acts like a subtype-selective inverse agonist in the αfive subtype of the benzodiazepine binding site within the GABAA receptor. might concentrate on several unique receptors), and https://friedricht875aky8.p2blogs.com/profile